Clinical Trial Update: Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating resiniferatoxin for refractory Morton's neuroma pain; the study has completed Phase 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morton Neuroma

Drugs mentioned

• Resiniferatoxin (resiniferatoxin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Morton's Neuroma | Phase 1 | Status: COMPLETED